文献速递主动脉疾病血液透析通路

既往外科显露或修复股动脉后经皮股动脉入路行主动脉瘤腔内修复的安全性

Safety of Percutaneous Femoral Access for Endovascular Aortic Aneurysm Repair Through Previously Surgically Exposed or Repaired Femoral Arteries.
PubMed 文献 · J Endovasc Ther · 2022-05-06

该回顾性研究纳入2010至2020年2个主动脉中心632例经皮(复杂)腹主动脉瘤腔内修复患者,比较既往外科显露或修复股动脉(再通组)与初次经皮穿刺(完整组)的技术成功与临床结局。再通组技术成功93.3% vs 完整组95.3%(p=0.311),入路相关外科修正0.7% vs 0.6%(p=0.950),入路并发症2.7% vs 4.0%(p=0.443)。结论认为既往开放股动脉显露或修复对经皮(复杂)主动脉瘤腔内修复的技术成功和临床结局无负面影响。

要点

  • 再通组与完整组技术成功、入路相关外科修正及入路并发症均无显著差异。
  • 全组入路并发症预测因素为主入路部位(OR 2.39)和手术时间每增加1小时(OR 1.65)。
  • 中转开放手术预测因素为主入路部位(OR 2.32)和入路血管周径50%至75%钙化(OR 3.29)。

核心结论

  • 在研究者所在人群中,既往开放股动脉显露或修复对经皮(复杂)主动脉瘤腔内修复的技术成功和临床结局无负面影响。

研究设计与样本

  • 回顾性研究,纳入2010年至2020年2个主要主动脉中心接受经皮(复杂)主动脉瘤腔内修复的患者,仅分析鞘管≥12Fr的穿刺。
  • 共632例患者,其中98例有既往开放股动脉入路(再通组),534例为初次经皮股动脉入路(完整组)。
  • 共1099次股动脉穿刺,再通腹股沟149次,完整腹股沟950次。
  • 腔内修复范围包括159例肾下、82例胸主动脉、368例开窗/分支和23例髂分支装置。
  • 两机构入路和(预)闭合技术相似,主要终点为术中技术成功、入路相关修正和入路并发症。

主要发现

  • 技术成功:再通组93.3% vs 完整组95.3%,p=0.311。
  • 入路相关外科修正:再通组0.7% vs 完整组0.6%,p=0.950。
  • 入路并发症:再通组2.7% vs 完整组4.0%,p=0.443。
  • 全组多变量分析中,入路并发症的显著预测因素为主入路部位(OR 2.39;95%CI 1.07%-5.35%;p=0.033)和手术时间每增加1小时(OR 1.65;95%CI 1.34%-2.04%;p<0.001),鞘管-血管比值增加有保护作用(OR 0.33;95%CI 0.127%-0.85%;p=0.021)。
  • 中转开放手术的预测因素为主入路部位(OR 2.32;95%CI 1.28%-4.19%;p=0.007)和入路血管周径50%至75%钙化(OR 3.29;95%CI 1.38%-7.86%;p=0.005)。

临床怎么用

  • 作者认为,在研究者所在人群中,既往开放股动脉显露或修复对经皮(复杂)主动脉瘤腔内修复的技术成功和临床结局无负面影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Percutaneous femoral artery access is being increasingly used in endovascular aortic repair (EVAR). The technique can be challenging in patients with previously surgically exposed or repaired femoral arteries because of excessive scar tissue. However, a successful percutaneous approach may cause less morbidity than a "re-do" open femoral approach. The aim of this study was to assess the impact of prior open surgical femoral exposure on technical success and clinical outcomes of percutaneous approach. METHODS: This study retrospectively reviewed the clinical data of patients who underwent percutaneous EVAR between 2010 and 2020 at 2 major aortic centers. Patients were divided into 2 groups (with or without prior open surgical femoral access) for analysis of clinical outcomes. Only punctures with sheaths ≥12Fr were included for analysis. The access and (pre)closure techniques were similar in both institutions. Primary end points were intraoperative technical success, access-related revision, and access complications. A multivariate analysis was performed to identify determinants of conversion to open approach and femoral access complications in intact and re-do groins. RESULTS: A total of 632 patients underwent percutaneous (complex) EVAR: 98 had prior open surgical femoral access and 534 patients underwent de novo femoral percutaneous access. A total of 1099 femoral artery punctures were performed: 149 in re-do and 950 in intact groins. The extent of endovascular repair included 159 infrarenal, 82 thoracic, 368 fenestrated/branched, and 23 iliac branch devices. No significant differences were seen in technical success (re-do 93.3% vs intact 95.3%, p=0.311), access-related surgical revision (0.7% vs 0.6%, p=0.950), and access complications (2.7% vs 4.0%, p=0.443). For the whole group, significant predictors for access complications in multivariate analyses were main access site (odds ratio [OR] 2.39; 95% confidence interval [CI] 1.07%-5.35%; p=0.033) and increase of the procedure time per hour (OR 1.65; 95% CI 1.34%-2.04%; p<0.001), while increase in sheath-vessel ratio had a protective effect (OR 0.33; 95% CI 0.127%-0.85%; p=0.021). Surgical conversion was predicted by main access site (OR 2.32; 95% CI 1.28%-4.19%; p=0.007) and calcification of 50% to 75% of the circumference of the access vessel (OR 3.29; 95% CI 1.38%-7.86%; p=0.005). CONCLUSION: Within our population prior open surgical femoral artery exposure or repair had no negative impact on the technical success and clinical outcomes of percutaneous (complex) endovascular aortic aneurysm repair.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Meertens MM, Tenorio ER, Lemmens CC, et al. Safety of Percutaneous Femoral Access for Endovascular Aortic Aneurysm Repair Through Previously Surgically Exposed or Repaired Femoral Arteries. J Endovasc Ther. 2022. PMID: 35514295. doi:10.1177/15266028221092980

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。